Literature DB >> 11286563

Developmental regulation of morphological differentiation of placental villous trophoblast in the baboon.

J S Babischkin1, D W Burleigh, T M Mayhew, G J Pepe, E D Albrecht.   

Abstract

The present study determined whether morphological differentiation of placental villous cytotrophoblasts into syncytiotrophoblast during primate pregnancy was developmentally regulated and whether oestrogen has a role in this process. Placental volumetric composition of the cytotrophoblast and syncytiotrophoblast was determined by the test-point counting method on days 45-54, 60, 100, and 170 of gestation (term=184 days) in untreated baboons, on day 60 after placental oestrogen production was prematurely elevated by administration of aromatizable androstenedione or oestradiol, and on day 170 after oestrogen production was suppressed by administration of aromatase inhibitor CGS 20267. Cytotrophoblast and syncytiotrophoblast volumes and oestrogen levels increased (P< 0.01) with advancing gestation. Due to the rise in syncytiotrophoblast volume (12-fold) exceeded that of the cytotrophoblast (threefold), the mean (sem) ratio of syncytiotrophoblast and cytotrophoblast volumes increased (P< 0.001) from 3.4 (0.5) ml on day 60 to 12.1 (2.8) ml on day 170. Androstenedione administration elevated serum oestradiol levels threefold (P< 0.01) and increased the ratio of syncytiotrophoblast: cytotrophoblast volumes on day 60 by 50 per cent (P< 0.03) to that normally observed on day 100. However, the ratio of trophoblast volumes was unaltered in oestradiol-treated and CGS 20267-treated baboons. It is concluded that there is a developmental increase in morphological differentiation of the placental villous trophoblast during primate pregnancy and that androstenedione potentially via its conversion to oestrogen has a role in this process. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286563     DOI: 10.1053/plac.2000.0621

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

Review 1.  Hormones and human trophoblast differentiation: a review.

Authors:  André Malassiné; Laurent Cronier
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Elevated progesterone and its impact on birth weight after fresh embryo transfers.

Authors:  Yetunde Ibrahim; Miriam J Haviland; Michele R Hacker; Alan S Penzias; Kim L Thornton; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2017-04-17       Impact factor: 3.412

3.  Moderate maternal nutrient restriction, but not glucocorticoid administration, leads to placental morphological changes in the baboon (Papio sp.).

Authors:  N Schlabritz-Loutsevitch; B Ballesteros; C Dudley; S Jenkins; G Hubbard; G J Burton; P Nathanielsz
Journal:  Placenta       Date:  2007-03-23       Impact factor: 3.481

4.  Vascular Endothelial Growth Factor Delivery to Placental Basal Plate Promotes Uterine Artery Remodeling in the Primate.

Authors:  Jeffery S Babischkin; Graham W Aberdeen; Jonathan R Lindner; Thomas W Bonagura; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

5.  Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization.

Authors:  Martin D Keltz; Daniel E Stein; Inna Berin; Josh Skorupski
Journal:  J Reprod Med       Date:  2012 Jan-Feb       Impact factor: 0.142

6.  Passive immunization against the MHC class I molecule Mamu-AG disrupts rhesus placental development and endometrial responses.

Authors:  Gennadiy I Bondarenko; David W Burleigh; Maureen Durning; Edith E Breburda; Richard L Grendell; Thaddeus G Golos
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

7.  Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer.

Authors:  Liping Zong; Peihao Liu; Liguang Zhou; Daimin Wei; Lingling Ding; Yingying Qin
Journal:  Reprod Biol Endocrinol       Date:  2020-05-04       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.